These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8775839)
1. The application of the principles of toxicology and teratology in evaluating the risks of new drugs for treatment of drug addiction in women of reproductive age. Brent RL NIDA Res Monogr; 1995; 149():130-84. PubMed ID: 8775839 [No Abstract] [Full Text] [Related]
2. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Brent RL Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188 [TBL] [Abstract][Full Text] [Related]
3. [A risk analysis of congenital defects due to drug intake during pregnancy. Spanish Collaborative Study of Congenital Malformations]. Martínez-Frías ML Med Clin (Barc); 1999 Jan; 112(2):41-4. PubMed ID: 10065427 [TBL] [Abstract][Full Text] [Related]
4. [Wilson's principles--a base of modern teratology]. Burdan F; Bełzek A; Szumiło J; Dudka J; Korobowicz A; Tokarska E; Klepacz L; Bełzek M; Klepacz R Pol Merkur Lekarski; 2006 Mar; 20(117):358-61. PubMed ID: 16780275 [TBL] [Abstract][Full Text] [Related]
5. [Congenital abnormalities. III. Drugs: their use and abuse]. Dulanto Gutiérrez E Gac Med Mex; 1975 Jun; 109(6):368-82. PubMed ID: 1149984 [No Abstract] [Full Text] [Related]
6. Assessment of teratogenic potential of therapeutic agents: preclinical toxicology. Frederick GL Clin Invest Med; 1985; 8(4):323-7. PubMed ID: 4075617 [TBL] [Abstract][Full Text] [Related]
7. Principles of human teratology: drug, chemical, and infectious exposure. Wilson RD; ; J Obstet Gynaecol Can; 2007 Nov; 29(11):911-917. PubMed ID: 17977495 [TBL] [Abstract][Full Text] [Related]
8. Risk of drug-induced congenital defects. De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237 [TBL] [Abstract][Full Text] [Related]
9. [Oromaxillofacial teratogenic effects of heavy and light drugs]. Piccirillo P; Belnome G; Serpico R Arch Stomatol (Napoli); 1990; 31(3):461-7. PubMed ID: 1965879 [TBL] [Abstract][Full Text] [Related]
10. [Reflections on the problem of the "critical period" in teratology]. Merker HJ Internist (Berl); 1988 Mar; 29(3):170-8. PubMed ID: 3288574 [No Abstract] [Full Text] [Related]
11. Drug and chemical risks to the fetus: occupational hazards for medical personnel. Mennuti MT Prog Clin Biol Res; 1980; 36():41-7. PubMed ID: 7403180 [No Abstract] [Full Text] [Related]
12. [Congenital defects and drugs of noninstitutional use]. Villalbí JR Med Clin (Barc); 1999 Jan; 112(2):57-8. PubMed ID: 10065431 [No Abstract] [Full Text] [Related]
13. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Brent RL Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191 [TBL] [Abstract][Full Text] [Related]
14. Annual commentary on human teratogens. Shepard TH Teratology; 2002 Dec; 66(6):275-7. PubMed ID: 12486759 [No Abstract] [Full Text] [Related]
15. Paternal exposure and counselling: experience of a Teratology Information Service. De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753 [TBL] [Abstract][Full Text] [Related]
16. Teratology Society position paper: recommendations for vitamin A use during pregnancy. Teratology; 1987 Apr; 35(2):269-75. PubMed ID: 3603408 [No Abstract] [Full Text] [Related]
17. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Kozer E; Costei AM; Boskovic R; Nulman I; Nikfar S; Koren G Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):70-84. PubMed ID: 12852485 [TBL] [Abstract][Full Text] [Related]
18. Principles and practice of teratology for the obstetrician. Fisher B; Rose NC; Carey JC Clin Obstet Gynecol; 2008 Mar; 51(1):106-18. PubMed ID: 18303504 [TBL] [Abstract][Full Text] [Related]
19. Reproductive risks associated with exposure to antineoplastic agents: a review of the literature. Hoffman DM Hosp Pharm; 1986 Oct; 21(10):930-2, 936, 940. PubMed ID: 10301074 [TBL] [Abstract][Full Text] [Related]
20. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project. Felix RJ; Jones KL; Johnson KA; McCloskey CA; Chambers CD; Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):944-7. PubMed ID: 15570610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]